Trial NCT03878095

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2019-01461
Secondary IDs: 10222 2000027026 NCI-2019-01461 UM1CA186689

Last trial update was posted on 2024-04-08

MeSH Interventions

Olaparib Poly(ADP-ribose) Polymerase Inhibitors

MeSH Conditions

Cholangiocarcinoma Neoplasms

Other Conditions

Malignant Solid Neoplasm Refractory Cholangiocarcinoma Refractory Malignant Solid Neoplasm

Stopping Reasons

Other - Pending Data Analysis

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID